Paper Details

  1. Home
  2. Paper Details

Pediatric Fatalities Associated With Over-the-Counter Cough and Cold Medications.

Author: BannerWilliam, BondG Randall, DartRichard C, Delva-ClarkHeather, GreenJody L, HalmoLaurie Seidel, KauffmanRalph E, PalmerRobert B, PaulIan M, Rapp-OlssonMalin, ReynoldsKate M, WangGeorge Sam

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study describes fatalities associated with exposures to over-the-counter cough and cold medications in children younger than 12 years old.
Paper Details　
Original Abstract of the Article :
In 2008, over-the-counter cough and cold medications (CCMs) underwent labeling changes in response to safety concerns, including fatalities, reported in children exposed to CCMs. The objective of this study is to describe fatalities associated with exposures to CCMs in children <12 years old that we...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1542/peds.2020-049536

データ提供：米国国立医学図書館（NLM）

Over-the-Counter Cough and Cold Medications: A Warning for Parents

The world of [over-the-counter medications] can be a confusing landscape for parents, especially when it comes to treating their children's illnesses. This study investigates the safety of [cough and cold medications (CCMs)] for children under the age of 12, focusing on a specific concern: [fatalities]. The researchers analyzed data from a [safety surveillance system] to identify fatalities associated with CCM exposures in children.

A Call for Caution: CCMs and Child Safety

This study reveals that fatalities have occurred in children who have been exposed to CCMs. The researchers emphasize the importance of following label instructions carefully and consulting with a healthcare professional before giving CCMs to children. This is particularly crucial for children under the age of 2, as they are at an increased risk of serious side effects from CCMs.

Navigating the Medical Landscape: A Guide for Parents

The results of this study highlight the importance of making informed decisions about medication use for children. It's essential for parents to be aware of potential risks associated with CCMs and to seek guidance from qualified healthcare professionals when treating their children's illnesses. By being informed and taking precautions, we can help to protect our children from potential harm and ensure their safety.

Dr. Camel's Conclusion

This study serves as a reminder of the importance of careful medication use for children. Like a camel navigating a treacherous desert, parents must be cautious and discerning in their approach to over-the-counter medications. By following label instructions, consulting with healthcare professionals, and prioritizing safety, we can help to ensure the well-being of our children and guide them safely through the challenging landscapes of childhood illnesses.

Date :
  1. Date Completed 2021-11-25
  2. Date Revised 2021-11-27
Further Info :

Pubmed ID

34607934

DOI: Digital Object Identifier

10.1542/peds.2020-049536

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.